查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467832

2024-2032 年黄斑部病变治疗市场报告（按类型、疾病阶段、给药途径、最终用户和地区）

Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球黄斑部病变治疗市场规模达94亿美元。

黄斑部病变是一种神经退化性眼部疾病，会影响眼睛并导致视野中心视力模糊或丧失。其特点是视野盲点、视觉扭曲、在低光源条件下看不清楚东西。一些常用的黄斑部病变治疗技术包括抗血管新生药物、光动力雷射疗法、隐形眼镜和过渡镜片。雷射治疗是将专门的隐形眼镜插入眼睛受影响的区域，并用雷射将其与血管一起密封。抗血管新生药物用于防止血管阻塞和渗漏。及时治疗黄斑部病变有助于增强视力并最大程度地降低慢性失明的风险。

黄斑部病变治疗市场趋势：

大众中老年黄斑部病变和肥胖发病率的增加是推动市场成长的关键因素之一。饮食模式的变化和久坐生活方式的日益普及正在导致黄斑部病变的发展。此外，智慧型手机、笔记型电脑和电视的使用日益增加，导致长时间和过多的萤幕时间也影响了这种疾病的发生。此外，视网膜基因疗法的发展，包括将腺相关病毒（AAV）注射到体内以预防异常血管的发育，也为市场成长提供了推动力。与此一致的是，医疗保健基础设施的显着改善正在对市场成长产生积极影响。其他因素，包括开发创新有效药物的广泛研发（R＆D）活动，以及政府为促进公共卫生而实施的各种倡议，预计将推动市场成长。

本报告回答的关键问题

  • 2023年全球黄斑部病变治疗市场规模有多大？
  • 2024-2032年全球黄斑部病变治疗市场的预期成长率是多少？
  • 推动全球黄斑部病变治疗市场的关键因素是什么？
  • COVID-19 对全球黄斑部病变治疗市场有何影响？
  • 全球黄斑部病变治疗市场按类型划分是怎样的？
  • 根据疾病阶段，全球黄斑部病变治疗市场的细分情况如何？
  • 根据给药途径，全球黄斑部病变治疗市场的细分情况如何？
  • 基于最终用户的全球黄斑部病变治疗市场的细分情况如何？
  • 全球黄斑部病变治疗市场的重点区域有哪些？
  • 全球黄斑部病变治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球黄斑部病变治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 干性老年黄斑部病变
    • 市场走向
    • 市场预测
  • 湿性老年黄斑部病变
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依疾病阶段

  • 早期
    • 市场走向
    • 市场预测
  • 中级阶段
    • 市场走向
    • 市场预测
  • 后期
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依管理途径

  • 静脉途径
    • 市场走向
    • 市场预测
  • 玻璃体内途径
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aerie Pharmaceuticals Inc.
    • Bausch Health Companies Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd
    • Iveric Bio Inc.
    • Novartis AG
    • Panoptica
    • Pfizer Inc.
    • Phio Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.
    • Regenxbio Inc.
    • Santen Pharmaceutical Co. Ltd.
Product Code: SR112024A5118

The global macular degeneration treatment market size reached US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

Macular Degeneration Treatment Market Trends:

The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global macular degeneration treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, stage of disease, route of administration and end user.

Breakup by Type:

Dry Age-related Macular Degeneration

Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

Early Stage

Intermediate Stage

Late Stage

Breakup by Route of Administration:

Intravenous Route

Intravitreal Route

Breakup by End User:

Hospitals

Ambulatory Surgical Center

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global macular degeneration treatment market in 2023?
  • 2. What is the expected growth rate of the global macular degeneration treatment market during 2024-2032?
  • 3. What are the key factors driving the global macular degeneration treatment market?
  • 4. What has been the impact of COVID-19 on the global macular degeneration treatment market?
  • 5. What is the breakup of the global macular degeneration treatment market based on the type?
  • 6. What is the breakup of the global macular degeneration treatment market based on the stage of disease?
  • 7. What is the breakup of the global macular degeneration treatment market based on the route of administration?
  • 8. What is the breakup of the global macular degeneration treatment market based on the end user?
  • 9. What are the key regions in the global macular degeneration treatment market?
  • 10. Who are the key players/companies in the global macular degeneration treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Macular Degeneration Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Dry Age-related Macular Degeneration
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wet Age-related Macular Degeneration
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Stage of Disease

  • 7.1 Early Stage
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intermediate Stage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Late Stage
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous Route
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intravitreal Route
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Center
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aerie Pharmaceuticals Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Iveric Bio Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Panoptica
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phio Pharmaceuticals
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Regeneron Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Regenxbio Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Santen Pharmaceutical Co. Ltd.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2023
  • Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2023
  • Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
  • Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
  • Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2024-2032
  • Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
  • Table 8: Global: Macular Degeneration Treatment Market: Key Players